A Case Report: Disseminated Talaromycosis Presenting With Umbilicated Papules in HIV Patient in Community Hospital setting
Keywords:
Disseminated Talaromycosis, Talaromyces marneffei, Salmonella typhi, umbilicated papules, Wright stain smearAbstract
Disseminated Talaromycosis is a fungal infection caused by Talaromyces marneffei, commonly found in immunocompromised patients, particularly HIV-infected individuals in Southeast Asia. Delayed diagnosis may lead to increased complications and mortality, especially in community hospital settings with limited diagnostic resources. Rapid diagnosis of Disseminated Talaromycosis can be achieved through recognition of umbilicated papular skin lesions, a pathognomonic finding, combined with skin scraping and Wright stain smear as an accessible preliminary diagnostic tool in community hospital settings. Furthermore, HIV-infected patients with severe immunosuppression may present with multiple concurrent opportunistic infections, making simultaneous collection of both bacterial and fungal blood cultures critically important. This case report therefore presents an HIV-infected patient with umbilicated papular skin lesions as the presenting complaint, who was diagnosed with Disseminated Talaromycosis using skin scraping and Wright stain as a preliminary diagnostic tool in a community hospital setting.
A 30-year-old Thai female HIV-infected patient with AIDS and a history of antiretroviral therapy non-adherence to TLD (Tenofovir/Lamivudine/Dolutegravir) for more than 3 years presented to Phra Ajarn Fun Arjaro Hospital with low-grade fever, weight loss, and umbilicated papular skin lesions on the face, extremities, and trunk. Her CD4 count on admission was 88 cells/mm3 (12.2%). Skin scraping with microscopic examination with Wright stain smear revealed yeast-form organisms with binary fission morphology, and blood fungal culture confirmed Talaromyces marneffei. Furthermore, hemocultures from 2 independent specimens yielded Salmonella typhi, confirming co-infection. Salmonella typhi bacteremia was treated with intravenous Ceftriaxone 2 gm daily for 2 weeks. Talaromycosis was treated with intravenous Amphotericin B 0.8 mg/kg/day for 2 weeks, followed by Itraconazole oral 200 mg every 8 hours for 3 days, then 200 mg every 12 hours for 10 weeks, then 200 mg daily until CD4 exceeded 100 cells/mm3. Cotrimoxazole (Trimethoprim 80 mg/Sulfamethoxazole 400 mg) 2 tabs daily was continued for opportunistic infection prophylaxis until CD4 exceeded 200 cells/mm3. Antiretroviral therapy was restarted 2 weeks after Amphotericin B initiation. At the 3-month post-discharge follow-up, the skin lesions showed significant improvement.
Conclusion: Umbilicated papules in a severely immunocompromised patient with HIV should raise suspicion for disseminated talaromycosis. Skin scraping with Wright staining may provide rapid supportive evidence in a community hospital while confirmatory fungal culture is pending. This case also highlights the need to consider concurrent infections and to obtain appropriate bacterial and fungal cultures when clinically indicated.
References
Panel on Opportunistic Infections in Adults and Adolescents with HIV. Talaromycosis (formerly penicilliosis). Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV.Bethesda (MD): National Institutes of Health; 2023.
Gugnani HC, Sood N. Epidemiology of Talaromycosis (Penicilliosis) Marneffei in India: An Update. Eur J Med Health Sci. 2020;2(5):1-7. doi:10.24018/ejmed.2020.2.5.478.
Pruksaphon K, Nosanchuk JD, Ratanabanangkoon K, Youngchim S. Talaromyces marneffei infection: virulence, intracellular lifestyle and host defense mechanisms. J Fungi (Basel). 2022;8(2):200.
Qin Y, Huang X, Chen H, Liu X, Li Y, Hou J, et al. Burden of Talaromyces marneffei infection in people living with HIV/AIDS in Asia during ART era: a systematic review and meta-analysis. BMC Infect Dis. 2020;20:551. doi: 10.1186/s12879-020-05260-8.
Vanittanakom N, Cooper CR Jr, Fisher MC, Sirisanthana T. Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clin Microbiol Rev. 2006;19(1):95–110.
Centers for Disease Control and Prevention. Talaromycosis (Penicilliosis): Signs and symptoms. Atlanta: CDC; 2023.
Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Histoplasmosis. In: Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV [Internet]. Rockville (MD): National Institutes of Health (US); 2024 [cited 2026 Mar 3]. Available from: https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/histoplasmosis
Chakrabarti A, Slavin MA. Endemic fungal infections in the Asia-Pacific region. Med Mycol. 2011;49(4):337–44. doi: 10.3109/13693786.2010.551426. PMID: 21114430.
Azar MM, Hage CA. Laboratory Diagnostics for Histoplasmosis. J Clin Microbiol. 2017 Jun;55(6):1612-1620. doi: 10.1128/JCM.02430-16.
Buraphat P, Pongpirul W, Suttha P. Disseminated histoplasmosis in a patient with HIV diagnosed by simple bedside investigations. BMJ Case Rep. 2017 Jun 24;2017:bcr2017220587. doi: 10.1136/bcr-2017-220587. PMID: 28647712; PMCID: PMC5535086.
Mitaka H, Perlman DC. Umbilicated papules in disseminated cryptococcosis. CMAJ. 2022 Aug 15;194(31):E1090. doi: 10.1503/cmaj.220354. PMID: 35970552.
Maziarz EK, Perfect JR. Cryptococcosis. Infect Dis Clin North Am. 2016;30(1):179–206. doi: 10.1016/j.idc.2015.10.006. PMID: 26739608.
Noguchi H, Matsumoto T, Kimura U, Hiruma M, Kusuhara M, Ihn H. Cutaneous cryptococcosis. Med Mycol J. 2019;60(4):101-107. doi:10.3314/mmj.19.008. Fig. 4b. PMID: 31787730.
Mohr C, Kucharzik T, Metze D, Bonsmann G. Molluscum contagiosum-like papules within the scope of disseminated infection with Mycobacterium avium complex in an AIDS patient. Hautarzt. 1996;47(8):634–7.
Kaul S, Kaur I, Mehta S, Singal A. Cutaneous tuberculosis. Part I: Pathogenesis, classification, and clinical features. J Am Acad Dermatol. 2023 Dec;89(6):1091–1103. doi: 10.1016/j.jaad.2021.12.063. Epub 2022 Feb 8. PMID: 35149149.
Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Rockville (MD): National Institutes of Health; 2024 [cited 2026 Mar 3]. Available from: https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/adult-adolescent-oi/guidelines-adult-adolescent-oi.pdf.
Chaiwarith R, Ruangsirinusorn S, Karnjanachan A, Tovanabutra N. Ulcerated nodule in patient with talaromycosis: re-visit a neglected disease in the era of antiretroviral therapy. Int J Infect Dis. 2022 Sep;122:81-82. doi: 10.1016/j.ijid.2022.05.014. Epub 2022 May 11. PMID: 35568361.
Department of Disease Control, Ministry of Public Health, Thailand. Thailand National Guidelines on HIV/AIDS Treatment and Prevention 2021/2022 [Internet]. Bangkok: Department of Disease Control; 2021 [cited 2026 Mar]. Available from: https://www.prepthai.net/Paper/HIVAIDS_
Guidelines.pdf
Cao C, Xi L, Chaturvedi V. Talaromycosis (penicilliosis) due to Talaromyces (Penicillium) marneffei: insights into the clinical trends of a major fungal disease 60 years after the discovery of the pathogen. Clin Microbiol Rev.2019;32(2):e00050-18.
European AIDS Clinical Society (EACS). EACS Guidelines version 12.1: Management of HIV infection and related conditions [Internet]. Brussels: European AIDS Clinical Society; Nov 2024 [cited 2025 Dec 15]. Available from: https://www.eacsociety.org/guidelines/eacs-guidelines.
Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011-23. doi: 10.1056/NEJMra041809. PMID: 15758012
European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017 Aug;67(2):370-398. doi: 10.1016/j.jhep.2017.03.021. PMID: 28427875.
Assi M, Lakkis IE, Wheat LJ. Talaromyces marneffei laboratory cross reactivity with Histoplasma and Blastomyces urinary antigen. Med Mycol Case Rep. 2019 Jun 21;26:7-9. doi: 10.1016/j.mmcr.2019.06.003. PMID: 31229614; PMCID: PMC7110611.
Lê-Bury G, Niedergang F. Defective Phagocytic Properties of HIV-Infected Macrophages: How Might They Be Implicated in the Development of Invasive Salmonella Typhimurium? Front Immunol. 2018 Mar 23;9:531. doi: 10.3389/fimmu.2018.00531. PMID: 29628924; PMCID: PMC5876300.
Feasey NA, Dougan G, Kingsley RA, Heyderman RS, Gordon MA. Invasive non-typhoidal Salmonella disease: an emerging and neglected tropical disease in Africa. Lancet. 2012;379(9835):2489–99. doi: 10.1016/S0140-6736(11)61752-2. PMID: 22587967.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
การละเมิดลิขสิทธิ์ถือเป็นความรับผิดชอบของผู้ส่งบทความโดยตรง
ผลงานที่ได้รับการตีพิมพ์ถือเป็นลิขสิทธิ์ของผู้นิพนธ์ ขอสงวนสิทธิ์มิให้นำเนื้อหา ทัศนะ หรือข้อคิดเห็นใด ๆ ของบทความในวารสารไปเผยแพร่ทางการค้าก่อนได้รับอนุญาตจากกองบรรณาธิการ อย่างเป็นลายลักษณ์อักษร